BRK-B vs KINS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
KINS presents a compelling value-growth opportunity, anchored by a stable Piotroski F-Score of 4/9 and a significant discount to its Graham Number ($23.5) and Intrinsic Value ($84.96). The company has undergone a massive earnings turnaround, evidenced by 149.6% YoY earnings growth and an exceptional ROE of 43.04%. While the current price of $15.08 is deeply undervalued relative to fundamentals, the bearish technical trend and poor liquidity ratios (Quick Ratio 0.18) suggest short-term volatility. Overall, the combination of a low P/E (5.24) and explosive growth outweighs the liquidity concerns.
Compare Another Pair
Related Comparisons
BRK-B vs KINS: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Kingstone Companies, Inc. (KINS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.